Does BROLUCIZUMAB Cause Off label use? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Off label use have been filed in association with BROLUCIZUMAB (BEOVU). This represents 9.1% of all adverse event reports for BROLUCIZUMAB.
62
Reports of Off label use with BROLUCIZUMAB
9.1%
of all BROLUCIZUMAB reports
3
Deaths
1
Hospitalizations
How Dangerous Is Off label use From BROLUCIZUMAB?
Of the 62 reports, 3 (4.8%) resulted in death, 1 (1.6%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB Cause?
Visual impairment (116)
Vision blurred (106)
Eye pain (81)
Vitreous floaters (74)
Vitritis (65)
Ocular hyperaemia (62)
Subretinal fluid (62)
Retinal vasculitis (52)
Eye inflammation (50)
Visual acuity reduced (50)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BROLUCIZUMAB Alternatives Have Lower Off label use Risk?
BROLUCIZUMAB vs BROLUCIZUMAB-DBLL
BROLUCIZUMAB vs BROMAZEPAM
BROLUCIZUMAB vs BROMFENAC
BROLUCIZUMAB vs BROMHEXINE
BROLUCIZUMAB vs BROMOCRIPTINE